--- library_name: transformers license: cc-by-sa-4.0 language: - en - ja base_model: - EQUES/JPharmatron-7B-base tags: - pharmacy - biology - chemistry - medical --- # JPharmatron-7B JPharmatron-7B is a 7B large language model designed for pharmaceutical applications and researches. ## Model Details ### Model Description The JPharmatron-7B is continually pre-trained using 8.8B tokens from Japanese and English datasets, based on Qwen2.5-7B. Compared to the JPharmatron-7B-base model, JPharmatron-7B has enhanced chat capabilities, obtained from Qwen2.5-7B-Instruct's chat vector. - **Developed by:** EQUES Inc. - **Funded by [optional]:** [GENIAC Project](https://www.meti.go.jp/policy/mono_info_service/geniac/index.html) - **Model type:** Causal decoder-only - **Language(s) (NLP):** Japanese, English - **License:** CC-BY-SA-4.0 ### Model Sources [optional] - **Repository:** https://github.com/EQUES-Inc/pharma-LLM-eval - **Paper [optional]:** [A Japanese Language Model and Three New Evaluation Benchmarks for Pharmaceutical NLP](https://arxiv.org/abs/2505.16661) ## Uses This model is intended for applications in pharmaceutical paperwork and research. It is not validated for medical use or any other risk-sensitive use. ## Evaluation We evaluated our model, JPharmatron-7B, with other general / domain-specific models of a similar size. ### Testing Data [JPharmaBench](https://huggingface.co/collections/EQUES/jpharmabench-680a34acfe96870e41d050d8) and two existing benchmarks (JMMLU (pharma) and IgakuQA) were used. ### Results Compared to Meditron3-Qwen2.5-7B and Llama3.1-Swallow-8B-Instruct-v0.3, JPharmatron-7B achieved the highest score on all of the five benchmarks. ![](evaluation.png) ## Citation [optional] **BibTeX:** ``` @misc{sukeda_japanese_2025, title = {A {Japanese} {Language} {Model} and {Three} {New} {Evaluation} {Benchmarks} for {Pharmaceutical} {NLP}}, url = {http://arxiv.org/abs/2505.16661}, doi = {10.48550/arXiv.2505.16661}, abstract = {We present a Japanese domain-specific language model for the pharmaceutical field, developed through continual pretraining on 2 billion Japanese pharmaceutical tokens and 8 billion English biomedical tokens. To enable rigorous evaluation, we introduce three new benchmarks: YakugakuQA, based on national pharmacist licensing exams; NayoseQA, which tests cross-lingual synonym and terminology normalization; and SogoCheck, a novel task designed to assess consistency reasoning between paired statements. We evaluate our model against both open-source medical LLMs and commercial models, including GPT-4o. Results show that our domain-specific model outperforms existing open models and achieves competitive performance with commercial ones, particularly on terminology-heavy and knowledge-based tasks. Interestingly, even GPT-4o performs poorly on SogoCheck, suggesting that cross-sentence consistency reasoning remains an open challenge. Our benchmark suite offers a broader diagnostic lens for pharmaceutical NLP, covering factual recall, lexical variation, and logical consistency. This work demonstrates the feasibility of building practical, secure, and cost-effective language models for Japanese domain-specific applications, and provides reusable evaluation resources for future research in pharmaceutical and healthcare NLP. Our model, codes, and datasets are released at https://github.com/EQUES-Inc/pharma-LLM-eval.}, urldate = {2025-05-30}, publisher = {arXiv}, author = {Sukeda, Issey and Fujii, Takuro and Buma, Kosei and Sasaki, Shunsuke and Ono, Shinnosuke}, month = may, year = {2025}, note = {arXiv:2505.16661 [cs]}, annote = {Comment: 15 pages, 9 tables, 5 figures} } ``` ## More Information [optional] See our preprint: [A Japanese Language Model and Three New Evaluation Benchmarks for Pharmaceutical NLP](https://arxiv.org/abs/2505.16661). ## Model Card Authors [optional] [@shinnosukeono](https://shinnosukeono.github.io/)